Article
Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
Cancer reports (Hoboken, N.J.) - 1 Sept 2024
Morita Meiko, Ono Akira, Sekikawa Motoki, Doshita Kosei, Miura Keita, Kodama Hiroaki, Yabe Michitoshi, Morikawa Noboru, Iida Yuko, Mamesaya Nobuaki, Kobayashi Haruki, Ko Ryo, Wakuda Kazushige, Kenmotsu Hirotsugu, Naito Tateaki, Murakami Haruyasu, Isaka Mitsuhiro, Ohde Yasuhisa, Takahashi Toshiaki
Abstract excerpt
BACKGROUND: Mutations in the epidermal growth factor receptor (EGFR) gene are the most common targetable gene alterations in non-small cell lung cancer (NSCLC). In Japan, approximately 40% of patients who undergo surgical resection for non-squamous NSCLC have EGFR mutations. However, no long-term studies have been conducted including a large number of EGFR-positive NSCLC patients with postoperative recurrence...
Topics
Join the communities discussing this publication.